Ramsay Sante : Results at the end of March 2023
2023年5月3日 - 12:35AM
Ramsay Sante : Results at the end of March 2023
PRESS
RELEASEParis, 2 May 2023
13.5% total revenues
growth for the third
quarter of this financial
year, up to €1.3bn
total revenues, supported by
a broad-based good dynamics and recent
acquisitions in the Nordics
countries. Growth on a
like-for-like
basis of
10.2%.
Continuously playing a leading role
in addressing the numerous
headwinds impacting the healthcare sector in
Europe. For the quarter, EBITDA decreased
by
€30m
leading to €137m
and 11.0% margin for this
quarter, due to lower subsidies, high inflation
and staff shortage challenges.
Cost controls measures reinforced to
address current situation
and pursue our Yes We Care
2025 strategic plan in
implementing a global patient pathway strategy
to further be a
European leader in integrated care.
- Unaudited
turnover for the nine months period ending 31 March 2023 amounted
to €3,462m up 10.2% on a reported basis. Unaudited turnover for the
last quarter amounted to €1,253m up 13.5% on a reported basis
;
- Unaudited EBITDA
for the nine months period ending 31 March 2023 amounted to €450m
down -10.5% on a reported basis. Unaudited EBITDA for the last
quarter amounted to €137m down -18.0% on a reported basis ;
- Unaudited
current operating profit for the nine months period ending 31 March
2023 amounted to €154m down -31.4% on a reported basis. Unaudited
current operating profit for the last quarter amounted to €41m down
-45.9% on a reported basis ;
- Ramsay Santé has
maintained its actions to participate in the support of the French
and Nordics public healthcare sectors. It has resulted in a 3.8%
increase in patient admissions in our acute care facilities and 1.1
million additional patient consultations in our Nordics primary
care centres over the 9 months ended 31 March 2023 compared to the
prior corresponding period.
- The group
continued its expansion in its core strategic development areas.
Two primary care centres opened their doors in late 2022 in France
and the Haussmann medical centre in central Paris joined the Ramsay
Santé network in January 2023. On 1st March 2023, the
Ange Gardien mental health clinic re-opened its doors following an
extensive redevelopment of the facility and merger of the
neighbouring Perreuse clinic into a single expanded modern site.
The 232 beds and 15 day places will significantly enhance the
mental health services proposed to the greater eastern
Ile-de-France region. Finally on1st April 2023, St Göran has opened
its new maternity ward in Stockholm.
- Activity levels
in France and the Nordics have been solid. Revenues for the group
increased by €149m or 13.5% for the January to March 2023 quarter
compared to the prior corresponding period. Adjusted for changes in
the scope of consolidation and at constant exchange rates, revenues
organic growth for the quarter ending 31 March 2023 was 10.2%.
France revenue has grown by 10.3% supported by an increase in
medical purchases rechargeable revenue and impacted by the ongoing
shift toward ambulatory care. Nordic countries revenue grew by
21.3% supported by recent acquisitions. On a like-for-like basis,
Nordics revenue growth is of 10.7% and is mainly realised in the
Nordics by proximity care and specialist care patients in both
Sweden and Denmark.
- The group
consolidated EBITDA for the quarter ending 31 March 2023 of €137m
decreased by €30m or-18% compared to the prior corresponding
period.
- Decrease of the
EBITDA this quarter is related to the drop of subsidies and revenue
guarantee received by government bodies, by continuing medical
staff shortage in all regions and by persistently higher inflation
conditions. The amount of various government subsidies related to
COVID, including revenue guarantee, have been lower by €52m for the
group this quarter compared to the same period last year,
reflecting the decreasing intensity of the COVID pandemia.
- In order to
mitigates these headwinds, Ramsay Santé has launched a set of
measures in order to better control its cost base while preserving
its Yes We Care 2025 strategic plan.
- Acquisitions
realised during the last Fiscal Year have been integrated as
expected. Regarding GHP, this acquisition represents an impact, for
the nine month period, of 121.9M€ of revenues, 16.1M€ of EBITDA and
7.8M€ of EBIT.
- The French
tariffs applicable from 1st March 2023 have been released. MSO
tariffs increase by +5.4% and re-incorporate into DRG price the
2022 funding of operating costs inflation that had been received
through grants in H1 FY23. Rehabilitation and follow-up care
tariffs increase by +1.9%.
- Finally, the
French Government has indicated it will prolong its support to the
industry through a modified revenue guarantee scheme extending to
31st December 2023, with a less favourable scheme however.
- Ramsay Health
Care Ltd is publishing in parallel a trading update as at end of
March 2023, which includes some of the information contained in
this announcement.
Pascal Roché, Chief Executive Officer of
Ramsay Santé, says:
« The third quarter of FY23 (January to
March 2023) has seen, once again, Ramsay Santé and all its
employees and medical community being able to serve the healthcare
sector and its patients in both France and the 3 Nordics countries
despite the scarcity of resources and the inflation burden. »
The Board of Directors approved the unaudited third quarter FY23
trading update at its meeting heldon 2nd May 2023.
About Ramsay Santé
Ramsay Santé is the leader in private
hospitalisation and primary care in Europe. The Group has 36,000
employees and works with nearly 9,300 practitioners to treat more
than 10 million patients per year in its 443 facilities and 5
countries: France, Sweden, Norway, Denmark and Italy.
Ramsay Santé offers almost all medical and
surgical specialities in three domains: Medicine, Surgery,
Obstetrics (MSO), Follow-up Care and Rehabilitation (FCR) and
Mental Health. In all its territories, the Group contributes to
public service health undertakings and providing proximity care, as
in Sweden where the group has more than a hundred local health
centres. Safe, quality care is the Group's priority in all the
countries where it operates. This is what has made it a reference
in state-of-the-art medicine, particularly in outpatient surgery
and enhanced recovery after surgery (ERAS). The Group also invests
more than €200 million every year in its facilities, whether in new
surgical and imaging technologies or in the construction and
modernisation of facilities. To best serve patient interests, it
innovates constantly with new digital tools and by developing its
organisations to improve efficiency of care.
Facebook: https://www.facebook.com/RamsaySanteInstagram:
https://www.instagram.com/ramsaysanteTwitter:
https://twitter.com/RamsaySanteLinkedIn:
https://www.linkedin.com/company/ramsaysanteYouTube:
https://www.youtube.com/c/RamsaySante
Code ISIN and Euronext Paris:
FR0000044471Website:
www.ramsaygds.fr
Investor / Analyst
Relations Press
Relations
Jérôme
Brice Brigitte
CachonTel. +33 1 87 86 21
88 Tel. +33 1 87 86
22
11Jerome.brice@ramsaysante.fr brigitte.cachon@ramsaysante.fr
- RAMSAY SANTE - results at the end of March 2023
Ramsay Generale De Sante (LSE:0OD6)
過去 株価チャート
から 4 2024 まで 5 2024
Ramsay Generale De Sante (LSE:0OD6)
過去 株価チャート
から 5 2023 まで 5 2024